Organization
University of Witwatersrand
3 clinical trials
1 abstract
Clinical trial
Evaluation of Persistence of Immunogenicity Following an Open-labelled, Randomized Controlled Trial Evaluating Non-inferiority of 1+1 Compared to 2+1 Dosing Schedules of 10-valent and 13-valent Pneumococcal Conjugate Vaccine in South AfricaStatus: Completed, Estimated PCD: 2022-12-01
Clinical trial
Acceptability and Feasibility of Injectable Cabotegravir Pre-exposure Prophylaxis (PrEP) Versus Oral PrEP in Routine Care up to 15 Months in Private Pharmacies in South AfricaStatus: Active (not recruiting), Estimated PCD: 2025-10-31
Abstract
A misunderstood burden – living with sle in south africaOrg: University of Cape Town, University of Witwatersrand,
Clinical trial
Post-Injectable Cabotegravir Antiretroviral Salvage Strategy Options TrialStatus: Active (not recruiting), Estimated PCD: 2026-06-30